Legal & General Group PLC Innoviva, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 166,727 shares of INVA stock, worth $3.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

166,727

Previous 163,742 1.82%

Holding current value

$3.22 Million

Previous $2.5 Million 9.58%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.4 - $16.4 $42,984 - $48,953	2,985 Added 1.82%	166,727 $2.73 Million
Q1 2024 May 14, 2024	BUY	$14.56 - $16.78 $2,868 - $3,305	197 Added 0.12%	163,742 $2.5 Million
Q4 2023 Feb 15, 2024	SELL	$12.32 - $16.27 $42,257 - $55,806	-3,430 Reduced 2.05%	163,545 $2.62 Million
Q3 2023 Nov 14, 2023	SELL	$12.37 - $13.89 $109,016 - $122,412	-8,813 Reduced 5.01%	166,975 $2.17 Million
Q2 2023 Aug 14, 2023	SELL	$11.39 - $13.72 $74,798 - $90,099	-6,567 Reduced 3.6%	175,788 $2.24 Million
Q1 2023 May 15, 2023	SELL	$10.73 - $13.6 $14,893 - $18,876	-1,388 Reduced 0.76%	182,355 $2.05 Million
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $5,569 - $6,504	472 Added 0.26%	183,743 $2.43 Million
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $77,485 - $101,578	-6,674 Reduced 3.51%	183,271 $2.13 Million
Q2 2022 Aug 22, 2022	BUY	$14.32 - $19.88 $51,308 - $71,230	3,583 Added 1.92%	189,945 $2.8 Million
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $21,207 - $27,904	-1,378 Reduced 0.73%	186,362 $3.61 Million
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $67,887 - $79,878	4,267 Added 2.33%	187,740 $3.24 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $144,717 - $191,036	11,081 Added 6.43%	183,473 $3.07 Million
Q2 2021 Aug 12, 2021	SELL	$11.45 - $13.96 $504,303 - $614,854	-44,044 Reduced 20.35%	172,392 $2.31 Million
Q1 2021 May 17, 2021	BUY	$11.06 - $12.87 $24,497 - $28,507	2,215 Added 1.03%	216,436 $2.59 Million
Q4 2020 Feb 12, 2021	SELL	$9.33 - $12.48 $1,511 - $2,021	-162 Reduced 0.08%	214,221 $2.66 Million
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $104,394 - $146,435	-10,106 Reduced 4.5%	214,383 $2.24 Million
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $161,112 - $213,975	14,022 Added 6.66%	224,489 $3.14 Million
Q1 2020 May 14, 2020	BUY	$8.11 - $15.23 $2,132 - $4,005	263 Added 0.13%	210,467 $2.48 Million
Q4 2019 Feb 13, 2020	BUY	$10.28 - $14.38 $285,969 - $400,022	27,818 Added 15.25%	210,204 $2.98 Million
Q3 2019 Nov 13, 2019	BUY	$10.05 - $14.55 $93,816 - $135,824	9,335 Added 5.39%	182,386 $1.92 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $15,720 - $17,940	-1,200 Reduced 0.69%	173,051 $2.52 Million
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $217,903 - $319,295	15,917 Added 10.05%	174,251 $2.45 Million
Q4 2018 Feb 15, 2019	SELL	$13.96 - $18.26 $7,789 - $10,189	-558 Reduced 0.35%	158,334 $2.75 Million
Q3 2018 Nov 20, 2018	BUY	$13.63 - $15.7 $123,487 - $142,242	9,060 Added 6.05%	158,892 $2.43 Million
Q2 2018 Aug 10, 2018	BUY	$13.44 - $17.59 $79,860 - $104,519	5,942 Added 4.13%	149,832 $2.07 Million
Q1 2018 May 17, 2018	SELL	$13.8 - $16.99 $62,638 - $77,117	-4,539 Reduced 3.06%	143,890 $2.41 Million
Q4 2017 Feb 13, 2018	BUY	$11.73 - $14.75 $1.74 Million - $2.19 Million	148,429	148,429 $2.11 Million

Others Institutions Holding INVA

# of Institutions

222

Shares Held

79.7M

Call Options Held

20K

Put Options Held

5.4K

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.35B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Innoviva, Inc. Transaction History